Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks

MeSH terms

• Adolescent
• Antineoplastic Agents / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bleomycin / therapeutic use
• Child
• Cyclophosphamide / therapeutic use
• Doxorubicin / therapeutic use
• Female
• Hodgkin Disease / drug therapy*
• Hodgkin Disease / radiotherapy
• Humans
• Male
• Prednisone / therapeutic use
• Procarbazine / therapeutic use
• Prognosis
• Risk Assessment
• Treatment Outcome*
• Vinblastine / therapeutic use
• Vincristine / therapeutic use